- Semaglutide and cardiovascular outcomes in patients with type 2 diabetes
People with prediabetes tend to show higher-than-normal-range numbers on an A1C, fasting glucose, or oral glucose tolerance tests
Other GLP-1 tablets, like orforglipron, could become available for weight loss in 2026 after it has been approved by the UKs Medicines and Healthcare products Regulatory Agency (MHRA)
Our professionals at ProCare Health highly recommend you speak with your healthcare team on whether semaglutide or tirzepatide is the best option for you by weighing the risks versus the benefits as you would with any medical treatment, medication, or new nutritional supplement
Prescription anti-nausea drugs can be prescribed if symptoms remain severe, though most patients find dietary modifications sufficient once they understand the adjustment period
Retatrutide is an attempt to leap beyond current incretin therapy by adding GIP and glucagon biology to GLP-1